@misc{10902/33652, year = {2024}, month = {6}, url = {https://hdl.handle.net/10902/33652}, abstract = {La Enfermedad Pulmonar Obstructiva Crónica (EPOC) es una enfermedad respiratoria crónica progresiva que representa un importante problema de salud pública a nivel mundial. Los pacientes con EPOC enfrentan un riesgo cardiovascular incrementado, lo que contribuye significativamente a su morbilidad y mortalidad. En este estudio observacional prospectivo se describe el riesgo cardiovascular de una cohorte de pacientes con EPOC y se evalúa qué variables clínicas se asocian con mayor riesgo cardiovascular. Además, se evalúa si esta herramienta puede utilizarse como un factor predictivo y pronóstico en agudizaciones e ingresos en estos pacientes. Del total de 117 pacientes, se han establecido dos grupos, de alto y bajo riesgo cardiovascular, en función de la categorización (Advanced risk, Smart risk y Score2) realizada siguiendo las escalas de riesgo cardiovascular ajustadas, para posteriormente analizar en cada uno de estos grupos diferentes variables y determinar si se asocian a un mayor riesgo de agudizaciones. Se ha comprobado que hay una alta prevalencia de diabetes mellitus, AOS, HTA y dislipemia en pacientes EPOC y que las escalas de riesgo cardiovascular no predicen las agudizaciones}, abstract = {The Chronic Obstructive Pulmonary Disease (COPD) is a progressive chronic respiratory disease that represents a significant worldwide public health problem. Patients with COPD face an increased cardiovascular risk, which significantly contributes to their morbidity and mortality. In this prospective observational study, the cardiovascular risk of a cohort of patients with COPD is described, and which clinical variables are associated with a higher cardiovascular risk are evaluated. Additionally, it is assessed whether this tool can be used as a predictive and prognostic factor in exacerbations and hospital admissions. Out of a total of 117 patients, two groups have been established, with high and low cardiovascular risk, based on the categorization (Advanced risk, Smart risk, and Score2) performed according to adjusted cardiovascular risk scales. Subsequently, different variables in each of these groups are analyzed to determine if they are associated with a higher risk of exacerbations. It has been proven that there is a high prevalence of diabetes mellitus, OSA, HTN and dyslipidaemia in COPD patients, and that cardiovascular risk scales do not predict exacerbations.}, title = {Escala de riesgo cardiovascular en pacientes con EPOC}, author = {Insua López, Ana Isabel}, }